| (+)-taxifolin | increases expression | ISO | RGD:736060 | 6480464 | taxifolin results in increased expression of GSTM1 mRNA | CTD | PMID:17541156 |
| (R)-lipoic acid | multiple interactions | ISO | RGD:10697 | 6480464 | [Dietary Fats co-treated with Thioctic Acid] results in increased expression of GSTM1 mRNA | CTD | PMID:18367378 |
| 1-benzofuran | affects expression | ISO | RGD:10697 | 6480464 | benzofuran affects the expression of GSTM1 mRNA | CTD | PMID:17114358 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:3570286 PMID:9545290 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:9545290 PMID:3570286 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | CTD | PMID:2904809 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [Dinitrochlorobenzene analog co-treated with Glutathione] | CTD | PMID:8867999 |
| 1-chloro-2,4-dinitrobenzene | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione]; more ... | CTD | PMID:2375757 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | ISO | RGD:10697 | 6480464 | GSTM1 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:12069689 |
| 1-chloro-2,4-dinitrobenzene | affects metabolic processing | EXP | | 6480464 | GSTM1 protein affects the metabolism of Dinitrochlorobenzene | CTD | PMID:11368767 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of GSTM1 mRNA | CTD | PMID:17351261 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of GSTM1 mRNA | CTD | PMID:15834898 |
| 1H-imidazole | increases expression | EXP | | 6480464 | imidazole results in increased expression of GSTM1 mRNA | CTD | PMID:8951341 |
| 1H-pyrazole | increases expression | ISO | RGD:10697 | 6480464 | pyrazole results in increased expression of GSTM1 protein | CTD | PMID:14610226 |
| 1H-pyrazole | increases expression | ISO | RGD:10697 | 6480464 | pyrazole results in increased expression of GSTM1 mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10697 | 6480464 | [Iron-Dextran Complex co-treated with Tetrachlorodibenzodioxin] results in increased expression of GSTM1 protein | CTD | PMID:9443932 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:15034205 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GSTM1 mRNA | CTD | PMID:20702594 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | CTD | PMID:7585625 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:19474220 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:18172886 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 protein | CTD | PMID:9443932 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:17949056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10697 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM1 mRNA | CTD | PMID:16214954 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10697 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GSTM1 mRNA | CTD | PMID:20702594 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10697 | 6480464 | NFE2L2 protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA] | CTD | PMID:19474220 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:736060 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GSTM1 mRNA | CTD | PMID:12377990 |
| 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of GSTM1 mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of GSTM1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of GSTM1 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of GSTM1 mRNA | CTD | PMID:17070881 |
| 2-amino-7-methyl-1,7-dihydro-6H-purin-6-one | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to and affects the metabolism of 7-methylguanine | CTD | PMID:15066569 |
| 2-nitropropane | increases expression | EXP | | 6480464 | 2-nitropropane results in increased expression of GSTM1 mRNA | CTD | PMID:17070881 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:10697 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM1 mRNA | CTD | PMID:18723825 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of GSTM1 mRNA | CTD | PMID:20959002 |
| 3,3'-diindolylmethane | decreases expression | ISO | RGD:736060 | 6480464 | 3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA | CTD | PMID:19770484 |
| 3,3'-diindolylmethane | multiple interactions | ISO | RGD:736060 | 6480464 | [3,3'-diindolylmethane results in decreased expression of GSTM1 mRNA] which results in increased abundance of aflatoxin B1-DNA adduct | CTD | PMID:19770484 |
| 3,4-dihydroxyphenylacetaldehyde | affects binding | EXP | | 6480464 | 3,4-dihydroxyphenylacetaldehyde binds to GSTM1 protein | CTD | PMID:21238438 |
| 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of GSTM1 mRNA | CTD | PMID:11328961 |
| 3-methylpyridine | decreases expression | ISO | RGD:736060 | 6480464 | 3-methylpyridine results in decreased expression of GSTM1 protein | CTD | PMID:7986210 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 PMID:19695238 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of GSTM1 mRNA | CTD | PMID:19695238 PMID:19162173 |
| 3H-1,2-dithiole-3-thione | multiple interactions | ISO | RGD:10697 | 6480464 | NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GSTM1 mRNA] | CTD | PMID:18367636 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:10697 | 6480464 | 1,2-dithiol-3-thione results in increased expression of GSTM1 mRNA | CTD | PMID:18367636 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:10697 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of GSTM1 mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | affects metabolic processing | EXP | | 6480464 | GSTM1 protein affects the metabolism of 4-hydroxy-2-nonenal analog | CTD | PMID:11256969 |
| 4-hydroxynon-2-enal | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTM1 protein co-treated with 4-hydroxy-2-nonenal] results in decreased abundance of Glutathione; more ... | CTD | PMID:21925487 |
| 4-hydroxynon-2-enal | multiple interactions | EXP | | 6480464 | [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog | CTD | PMID:11256969 |
| 4-nitro-1,2-phenylenediamine | increases expression | EXP | | 6480464 | 1,2-diamino-4-nitrobenzene results in increased expression of GSTM1 mRNA | CTD | PMID:17070881 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:736060 | 6480464 | alitretinoin results in decreased expression of GSTM1 mRNA | CTD | PMID:15982314 |
| acetylsalicylic acid | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 mutant form affects the susceptibility to Aspirin | CTD | PMID:16433794 |
| acrylamide | multiple interactions | ISO | RGD:736060 | 6480464 | [CYP2E1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the metabolism of Acrylamide; more ... | CTD | PMID:19131562 |
| acrylamide | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the metabolism of Acrylamide | CTD | PMID:19131562 PMID:21402133 |
| acrylamide | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTM1 gene polymorphism affects the metabolism of Acrylamide] which affects the chemical synthesis of N-acetyl-S-(2-carbamoylethyl)cysteine | CTD | PMID:21402133 |
| acrylamide | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the metabolism of Acrylamide | CTD | PMID:19131562 |
| aflatoxin B1 | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form results in increased susceptibility to Aflatoxin B1 | CTD | PMID:7892276 |
| aflatoxin B1 | decreases expression | ISO | RGD:10697 | 6480464 | Aflatoxin B1 results in decreased expression of GSTM1 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 exo-8,9-epoxide | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of and results in decreased activity of aflatoxin B1-2,3-oxide | CTD | PMID:1638515 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:736060 | 6480464 | Tretinoin metabolite results in decreased expression of GSTM1 mRNA | CTD | PMID:15982314 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736060 | 6480464 | Tretinoin results in increased expression of GSTM1 mRNA | CTD | PMID:15498508 |
| alpha-methyl-L-dopa | decreases activity | ISO | RGD:736060 | 6480464 | Methyldopa analog results in decreased activity of GSTM1 protein | CTD | PMID:8131222 |
| alpha-tocotrienol | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha] | CTD | PMID:15668500 |
| aminoguanidine | multiple interactions | ISO | RGD:10697 | 6480464 | pimagedine inhibits the reaction [Spermidine results in increased expression of GSTM1 mRNA] | CTD | PMID:12763045 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GSTM1 mRNA | CTD | PMID:16483693 |
| angelica lactone | increases expression | ISO | RGD:10697 | 6480464 | angelica lactone results in increased expression of GSTM1 protein | CTD | PMID:11309284 |
| aristolochic acid | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of GSTM1 mRNA | CTD | PMID:17483316 |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of GSTM1 mRNA | CTD | PMID:18178546 |
| arsenic atom | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form results in decreased susceptibility to Arsenic | CTD | PMID:16353154 |
| arsenic atom | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the susceptibility to Arsenic | CTD | PMID:18053222 |
| arsenic atom | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 polymorphism affects the metabolism of Arsenic | CTD | PMID:17365577 |
| arsenic atom | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the metabolism of and affects the susceptibility to Arsenic | CTD | PMID:17365577 |
| arsenite(3-) | increases expression | ISO | RGD:10697 | 6480464 | arsenite results in increased expression of GSTM1 mRNA | CTD | PMID:18929588 |
| asbestos | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism results in increased susceptibility to Asbestos | CTD | PMID:18420450 |
| atrazine | multiple interactions | ISO | RGD:10697 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM1 mRNA | CTD | PMID:22515965 |
| azathioprine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Azathioprine | CTD | PMID:17206640 |
| azathioprine | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Azathioprine | CTD | PMID:20434437 PMID:18155239 |
| azathioprine | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Azathioprine | CTD | PMID:18155239 PMID:20434437 |
| benzene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form affects the susceptibility to Benzene | CTD | PMID:14694614 |
| benzene | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism results in increased susceptibility to Benzene | CTD | PMID:15226677 PMID:15748501 |
| benzene | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Benzene | CTD | PMID:15226677 |
| benzene | increases metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein results in increased metabolism of Benzene | CTD | PMID:17885617 |
| benzene | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism results in increased susceptibility to Benzene | CTD | PMID:15748501 PMID:15226677 |
| benzene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Benzene | CTD | PMID:15226677 |
| benzene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the reaction [GSTT1 gene polymorphism affects the reaction [NQO1 gene SNP results in increased susceptibility to Benzene]] | CTD | PMID:17178637 |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:19770486 PMID:20127859 |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:15034205 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10697 | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of GSTM1 mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein inhibits the reaction [CYP1A1 protein promotes the reaction [Benzo(a)pyrene results in increased mutagenesis of HPRT1 gene]]; more ... | CTD | PMID:17525473 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736060 | 6480464 | Benzo(a)pyrene results in decreased expression of GSTM1 mRNA | CTD | PMID:17253728 |
| benzo[a]pyrene | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Benzo(a)pyrene metabolite | CTD | PMID:17525473 |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:20127859 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:21569818 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10697 | 6480464 | Benzo(a)pyrene results in increased expression of GSTM1 mRNA | CTD | PMID:20127859 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein polymorphism affects the metabolism of and affects the activity of Benzo(a)pyrene | CTD | PMID:15298956 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [Benzo(a)pyrene co-treated with Glutathione] | CTD | PMID:9403173 |
| benzo[a]pyrene | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism results in increased susceptibility to Benzo(a)pyrene | CTD | PMID:7728947 |
| benzo[a]pyrene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Benzo(a)pyrene | CTD | PMID:15471894 |
| benzothiazole | increases expression | EXP | | 6480464 | benzothiazole results in increased expression of GSTM1 mRNA | CTD | PMID:8951341 |
| benzyl isothiocyanate | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of benzyl isothiocyanate | CTD | PMID:7826396 |
| beta-hexachlorocyclohexane | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to beta-hexachlorocyclohexane | CTD | PMID:22310945 |
| bilirubin | decreases expression | ISO | RGD:736060 | 6480464 | Bilirubin results in decreased expression of GSTM1 mRNA | CTD | PMID:20196124 |
| bis(2-chloroethyl) sulfide | decreases expression | ISO | RGD:10697 | 6480464 | Mustard Gas results in decreased expression of GSTM1 mRNA | CTD | PMID:18955075 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10697 | 6480464 | Diethylhexyl Phthalate results in increased expression of GSTM1 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10697 | 6480464 | Diethylhexyl Phthalate results in increased expression of GSTM1 mRNA | CTD | PMID:19245819 PMID:19850644 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:10697 | 6480464 | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GSTM1 mRNA] | CTD | PMID:19850644 |
| bromobenzene | affects binding | EXP | | 6480464 | bromobenzene metabolite binds to GSTM1 protein | CTD | PMID:17305373 |
| bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of GSTM1 mRNA | CTD | PMID:12628495 |
| busulfan | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Busulfan | CTD | PMID:15142875 PMID:19584821 |
| busulfan | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan | CTD | PMID:21215809 |
| busulfan | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Busulfan | CTD | PMID:19584821 PMID:15142875 |
| busulfan | affects abundance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the abundance of Busulfan | CTD | PMID:20672371 |
| busulfan | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Busulfan | CTD | PMID:8886613 |
| busulfan | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Busulfan | CTD | PMID:15142875 |
| buta-1,3-diene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism promotes the reaction [EPHX1 gene polymorphism results in increased susceptibility to 1,3-butadiene] | CTD | PMID:11238181 |
| butyric acid | increases expression | EXP | | 6480464 | Butyric Acid results in increased expression of GSTM1 mRNA | CTD | PMID:12800193 |
| calcitriol | increases expression | ISO | RGD:736060 | 6480464 | Calcitriol results in increased expression of GSTM1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:736060 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GSTM1 mRNA | CTD | PMID:21592394 |
| carbamazepine | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form results in increased susceptibility to Carbamazepine | CTD | PMID:17465707 |
| carbamazepine | increases expression | EXP | | 6480464 | Carbamazepine results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 |
| carbon atom | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene SNP affects the susceptibility to Carbon | CTD | PMID:21138591 |
| carbon disulfide | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the metabolism of Carbon Disulfide | CTD | PMID:17333241 |
| carbon monoxide | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form affects the susceptibility to Carbon Monoxide | CTD | PMID:20194081 |
| carmustine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene affects the susceptibility to Carmustine | CTD | PMID:16087946 |
| carmustine | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Carmustine | CTD | PMID:20067466 |
| carmustine | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] | CTD | PMID:16087946 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GSTM1 mRNA | CTD | PMID:18500788 PMID:18172885 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GSTM1 mRNA | CTD | PMID:18172885 PMID:18500788 |
| chlorambucil | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Chlorambucil | CTD | PMID:20067466 PMID:15044619 |
| chlorambucil | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Chlorambucil | CTD | PMID:15044619 PMID:20067466 |
| chloroethene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the reaction [XRCC1 gene polymorphism affects the reaction [Vinyl Chloride affects the mutagenesis of TP53 gene]] | CTD | PMID:16097394 |
| chloroethene | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] results in increased susceptibility to Vinyl Chloride | CTD | PMID:16977343 |
| chloroprene | increases expression | ISO | RGD:10697 | 6480464 | Chloroprene results in increased expression of GSTM1 mRNA | CTD | PMID:23125180 |
| chlorpyrifos | affects expression | EXP | | 6480464 | Chlorpyrifos affects the expression of GSTM1 mRNA | CTD | PMID:19440498 |
| chlorpyrifos | multiple interactions | ISO | RGD:10697 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM1 mRNA | CTD | PMID:22515965 |
| chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of GSTM1 mRNA | CTD | PMID:17452286 |
| chrysene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [chrysene co-treated with Glutathione] | CTD | PMID:9403173 |
| ciprofibrate | decreases expression | EXP | | 6480464 | ciprofibrate results in decreased expression of GSTM1 mRNA | CTD | PMID:7676460 |
| cis-caffeic acid | decreases activity | EXP | | 6480464 | caffeic acid results in decreased activity of GSTM1 protein | CTD | PMID:8340025 |
| cisplatin | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] | CTD | PMID:16087946 |
| cisplatin | increases expression | ISO | RGD:10697 | 6480464 | Cisplatin results in increased expression of GSTM1 mRNA | CTD | PMID:21151649 |
| cisplatin | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 |
| cisplatin | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to [Paclitaxel co-treated with Cisplatin] | CTD | PMID:12851839 |
| clofibrate | affects response to substance | EXP | | 6480464 | GSTM1 affects the susceptibility to Clofibrate | CTD | PMID:16800819 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of GSTM1 mRNA | CTD | PMID:11328961 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of GSTM1 protein | CTD | PMID:16470657 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of GSTM1 mRNA | CTD | PMID:15860345 |
| clozapine | increases glutathionylation | ISO | RGD:736060 | 6480464 | GSTM1 protein results in increased glutathionylation of Clozapine | CTD | PMID:20849150 |
| clozapine | decreases activity | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased activity of Clozapine | CTD | PMID:20849150 |
| copper atom | multiple interactions | ISO | RGD:10697 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM1 mRNA | CTD | PMID:15467011 |
| copper(0) | multiple interactions | ISO | RGD:10697 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM1 mRNA | CTD | PMID:15467011 |
| cyclophosphamide | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene affects the susceptibility to [Carmustine co-treated with Cyclophosphamide co-treated with Cisplatin] | CTD | PMID:16087946 |
| cytarabine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Cytarabine | CTD | PMID:15713801 |
| daunorubicin | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Daunorubicin | CTD | PMID:15713801 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10697 | 6480464 | Tetrahydrocannabinol results in increased expression of GSTM1 mRNA | CTD | PMID:21542829 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of GSTM1 mRNA | CTD | PMID:1394205 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of GSTM1 mRNA | CTD | PMID:11328961 PMID:1394205 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of GSTM1 mRNA | CTD | PMID:1394205 PMID:11328961 |
| dexamethasone | increases expression | ISO | RGD:10697 | 6480464 | Dexamethasone results in increased expression of GSTM1 mRNA | CTD | PMID:21041162 |
| dexamethasone | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Dexamethasone | CTD | PMID:20067466 |
| dexamethasone | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein inhibits the reaction [Dexamethasone results in increased phosphorylation of BCL2L11 protein] | CTD | PMID:20067466 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20067466 |
| diarsenic trioxide | increases expression | ISO | RGD:736060 | 6480464 | arsenic trioxide results in increased expression of GSTM1 mRNA | CTD | PMID:20458559 PMID:22521957 |
| diarsenic trioxide | increases expression | ISO | RGD:736060 | 6480464 | arsenic trioxide results in increased expression of GSTM1 mRNA | CTD | PMID:20458559 |
| diazinon | increases expression | EXP | | 6480464 | Diazinon results in increased expression of GSTM1 mRNA | CTD | PMID:17452286 |
| dibenz[a,h]anthracene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione] | CTD | PMID:9403173 |
| dibenzo[a,l]pyrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of and results in decreased activity of [dibenzo(a,l)pyrene co-treated with Glutathione] | CTD | PMID:11849043 |
| diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of GSTM1 protein | CTD | PMID:21161181 |
| diethylstilbestrol | increases expression | ISO | RGD:10697 | 6480464 | Diethylstilbestrol results in increased expression of GSTM1 mRNA | CTD | PMID:21041162 |
| dimethyl sulfoxide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTM1 protein] | CTD | PMID:12370186 |
| dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:16436460 |
| dioxygen | decreases expression | ISO | RGD:736060 | 6480464 | Oxygen deficiency results in decreased expression of GSTM1 mRNA | CTD | PMID:19695866 |
| diphenylmethane-4,4'-diisocyanate | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein polymorphism results in increased susceptibility to 4,4'-diphenylmethane diisocyanate | CTD | PMID:11927838 |
| diquat | decreases expression | EXP | | 6480464 | Diquat results in decreased expression of GSTM1 mRNA | CTD | PMID:7676460 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of GSTM1 mRNA | CTD | PMID:21551480 |
| dopamine | decreases activity | ISO | RGD:736060 | 6480464 | Dopamine analog results in decreased activity of GSTM1 protein | CTD | PMID:8131222 |
| doxorubicin | multiple interactions | ISO | RGD:10697 | 6480464 | [copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of GSTM1 protein] which results in increased susceptibility to Doxorubicin | CTD | PMID:16289015 |
| doxorubicin | decreases response to substance | ISO | RGD:10697 | 6480464 | GSTM1 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:16289015 |
| doxorubicin | increases expression | ISO | RGD:10697 | 6480464 | Doxorubicin results in increased expression of GSTM1 mRNA | CTD | PMID:16243910 |
| elemental carbon | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene SNP affects the susceptibility to Carbon | CTD | PMID:21138591 |
| endosulfan | multiple interactions | ISO | RGD:10697 | 6480464 | [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of GSTM1 mRNA | CTD | PMID:22515965 |
| epichlorohydrin | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Epichlorohydrin | CTD | PMID:15091291 |
| ethacrynic acid | affects metabolic processing | ISO | RGD:10697 | 6480464 | GSTM1 protein affects the metabolism of Ethacrynic Acid | CTD | PMID:12069689 |
| ethanol | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Ethanol | CTD | PMID:15932176 |
| ethanol | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene mutant form affects the susceptibility to Ethanol | CTD | PMID:20171022 |
| etoposide | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Etoposide | CTD | PMID:15713801 |
| eugenol | decreases activity | ISO | RGD:736060 | 6480464 | Eugenol analog results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| eugenol | decreases activity | EXP | | 6480464 | Eugenol analog results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| felbamate | increases expression | EXP | | 6480464 | felbamate results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 |
| fluconazole | increases expression | ISO | RGD:10697 | 6480464 | Fluconazole results in increased expression of GSTM1 mRNA | CTD | PMID:16730040 |
| fumonisin B1 | increases expression | ISO | RGD:10697 | 6480464 | fumonisin B1 results in increased expression of GSTM1 mRNA | CTD | PMID:16221962 |
| furan | increases expression | ISO | RGD:10697 | 6480464 | furan results in increased expression of GSTM1 mRNA | CTD | PMID:20194422 |
| gabapentin | increases expression | EXP | | 6480464 | gabapentin results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 |
| glutathione | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [1,2,5,6-dibenzanthracene co-treated with Glutathione]; more ... | CTD | PMID:9403173 |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:7826396 more ... |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:9545290 more ... |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:9084911 more ... |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:9084911 more ... |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:8886613 more ... |
| glutathione | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTM1 protein co-treated with 4-hydroxy-2-nonenal] results in decreased abundance of Glutathione | CTD | PMID:21925487 |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:8886613 more ... |
| glutathione | increases expression | EXP | | 6480464 | Glutathione deficiency results in increased expression of GSTM1 mRNA | CTD | PMID:15345336 |
| glutathione | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [styrene oxide co-treated with Glutathione] | CTD | PMID:2604743 |
| glutathione | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] | CTD | PMID:8973562 |
| glutathione | affects metabolic processing | EXP | | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:6095330 |
| glutathione | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione analog] | CTD | PMID:2904809 |
| glutathione | multiple interactions | EXP | | 6480464 | Glutathione analog binds to and results in decreased activity of GSTM1 protein | CTD | PMID:1883342 |
| glutathione | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [Dinitrochlorobenzene co-treated with Glutathione]; more ... | CTD | PMID:2375757 |
| glutathione | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione]; more ... | CTD | PMID:8867999 |
| glutathione | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [hydratropic aldehyde co-treated with Glutathione] | CTD | PMID:11368548 |
| glutathione | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of Glutathione | CTD | PMID:9084911 more ... |
| glutathione | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of and results in decreased activity of [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide co-treated with Glutathione]; more ... | CTD | PMID:11849043 |
| glutathione | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of [15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Glutathione] | CTD | PMID:14979731 |
| haloperidol | increases expression | EXP | | 6480464 | Haloperidol results in increased expression of GSTM1 mRNA | CTD | PMID:15860345 |
| hexachlorobenzene | decreases expression | EXP | | 6480464 | Hexachlorobenzene results in decreased expression of GSTM1 mRNA | CTD | PMID:15159207 |
| hexamethylene diisocyanate | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein polymorphism results in increased susceptibility to 1,6-hexamethylene diisocyanate | CTD | PMID:11927838 |
| hydrogen peroxide | multiple interactions | ISO | RGD:736060 | 6480464 | [HP gene polymorphism co-treated with GSTM1 gene polymorphism] affects the susceptibility to Hydrogen Peroxide | CTD | PMID:20444272 |
| hydroquinone | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to hydroquinone | CTD | PMID:15141365 |
| indole-3-methanol | increases expression | ISO | RGD:10697 | 6480464 | indole-3-carbinol results in increased expression of GSTM1 protein | CTD | PMID:11309284 |
| indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:22129741 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of GSTM1 mRNA | CTD | PMID:18299717 |
| iron atom | increases expression | ISO | RGD:10697 | 6480464 | Iron results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:11755321 |
| iron atom | decreases expression | ISO | RGD:10697 | 6480464 | Iron results in decreased expression of GSTM1 protein | CTD | PMID:11755321 |
| isomethyleugenol | decreases activity | ISO | RGD:736060 | 6480464 | isomethyleugenol results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| isomethyleugenol | decreases activity | EXP | | 6480464 | isomethyleugenol results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| isotretinoin | decreases expression | ISO | RGD:736060 | 6480464 | Isotretinoin results in decreased expression of GSTM1 mRNA | CTD | PMID:15982314 |
| kojic acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; more ... | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha] | CTD | PMID:15668500 |
| L-ascorbic acid | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 affects the susceptibility to Ascorbic Acid deficiency | CTD | PMID:19710200 |
| L-cysteine | affects expression | EXP | | 6480464 | Cysteine affects the expression of GSTM1 mRNA | CTD | PMID:11040448 |
| lead diacetate | affects localization | EXP | | 6480464 | lead acetate affects the localization of GSTM1 protein | CTD | PMID:9750042 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GSTM1 protein | CTD | PMID:7878682 PMID:9750042 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GSTM1 protein | CTD | PMID:9750042 PMID:7878682 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of GSTM1 mRNA | CTD | PMID:9750042 |
| limonene | increases expression | EXP | | 6480464 | limonene results in increased expression of GSTM1 protein | CTD | PMID:23159986 |
| lipoic acid | multiple interactions | ISO | RGD:10697 | 6480464 | [Dietary Fats co-treated with Thioctic Acid] results in increased expression of GSTM1 mRNA | CTD | PMID:18367378 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSTM1 mRNA | CTD | PMID:18082333 |
| lithium atom | increases expression | EXP | | 6480464 | Lithium results in increased expression of GSTM1 protein | CTD | PMID:18296634 |
| lithocholic acid | multiple interactions | ISO | RGD:10697 | 6480464 | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of GSTM1 mRNA] | CTD | PMID:20977460 |
| lithocholic acid | increases expression | ISO | RGD:10697 | 6480464 | Lithocholic Acid results in increased expression of GSTM1 mRNA | CTD | PMID:20977460 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of GSTM1 mRNA | CTD | PMID:22406437 |
| melatonin | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with Melatonin] results in increased expression of GSTM1 mRNA | CTD | PMID:20033131 |
| melphalan | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Melphalan | CTD | PMID:20067466 |
| menadione | increases expression | ISO | RGD:10697 | 6480464 | Vitamin K 3 results in increased expression of GSTM1 mRNA | CTD | PMID:14610226 |
| mercaptopurine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to 6-Mercaptopurine | CTD | PMID:15713801 |
| mercury atom | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 mutant form affects the susceptibility to Mercury | CTD | PMID:20194072 |
| mercury atom | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTP1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the abundance of Mercury | CTD | PMID:19515364 |
| mercury atom | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 polymorphism affects the susceptibility to Mercury | CTD | PMID:17716707 |
| mercury dichloride | increases expression | ISO | RGD:10697 | 6480464 | Mercuric Chloride results in increased expression of GSTM1 protein | CTD | PMID:9434069 |
| mercury(0) | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 mutant form affects the susceptibility to Mercury | CTD | PMID:20194072 |
| mercury(0) | multiple interactions | ISO | RGD:736060 | 6480464 | [GSTP1 gene polymorphism co-treated with GSTM1 gene polymorphism] affects the abundance of Mercury | CTD | PMID:19515364 |
| mercury(0) | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 polymorphism affects the susceptibility to Mercury | CTD | PMID:17716707 |
| methamphetamine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Methamphetamine | CTD | PMID:15048646 |
| methamphetamine | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Methamphetamine | CTD | PMID:19254865 |
| methotrexate | affects expression | ISO | RGD:10697 | 6480464 | Methotrexate affects the expression of GSTM1 mRNA | CTD | PMID:18502557 |
| methotrexate | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Methotrexate | CTD | PMID:15713801 |
| methylarsonic acid | increases expression | EXP | | 6480464 | monomethylarsonic acid results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:16436460 |
| methylmercury chloride | decreases activity | EXP | | 6480464 | methylmercuric chloride results in decreased activity of GSTM1 protein | CTD | PMID:1793546 |
| methylmercury chloride | decreases expression | ISO | RGD:736060 | 6480464 | methylmercuric chloride results in decreased expression of GSTM1 mRNA | CTD | PMID:12215206 |
| microcystin-LR | decreases expression | ISO | RGD:10697 | 6480464 | cyanoginosin LR results in decreased expression of GSTM1 mRNA | CTD | PMID:17383702 |
| microcystin-LR | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein results in increased glutathionylation of and affects the susceptibility to cyanoginosin LR | CTD | PMID:21504230 |
| microcystin-LR | increases expression | ISO | RGD:10697 | 6480464 | cyanoginosin LR results in increased expression of GSTM1 mRNA | CTD | PMID:17654400 |
| monocrotaline | multiple interactions | ISO | RGD:10697 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein | CTD | PMID:21224054 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:736060 | 6480464 | Acetylcysteine inhibits the reaction [alpha-methylepinine results in increased expression of GSTM1 mRNA] | CTD | PMID:21871945 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein; more ... | CTD | PMID:12725062 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:22129741 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA | CTD | PMID:20045035 PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA | CTD | PMID:18754104 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTM1 protein | CTD | PMID:20935162 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] | CTD | PMID:20045035 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:20033131 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA | CTD | PMID:18164116 PMID:20045035 |
| naphthalene | affects expression | ISO | RGD:10697 | 6480464 | naphthalene affects the expression of GSTM1 protein | CTD | PMID:10959795 |
| naphthalene | decreases expression | ISO | RGD:10697 | 6480464 | naphthalene results in decreased expression of GSTM1 protein | CTD | PMID:19438287 |
| naphthalene | increases expression | ISO | RGD:736060 | 6480464 | naphthalene results in increased expression of GSTM1 mRNA | CTD | PMID:20500019 |
| naphthalene-1,5-diamine | affects expression | ISO | RGD:10697 | 6480464 | 1,5-naphthalenediamine affects the expression of GSTM1 mRNA | CTD | PMID:17114358 |
| nitric oxide | increases expression | ISO | RGD:10697 | 6480464 | Nitric Oxide deficiency results in increased expression of GSTM1 mRNA | CTD | PMID:15878706 |
| nitrogen dioxide | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 affects the susceptibility to Nitrogen Dioxide | CTD | PMID:22732554 |
| O-methyleugenol | decreases activity | ISO | RGD:736060 | 6480464 | methyleugenol results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| O-methyleugenol | decreases activity | EXP | | 6480464 | methyleugenol results in decreased activity of GSTM1 protein | CTD | PMID:8620581 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of GSTM1 protein | CTD | PMID:17110534 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of GSTM1 mRNA | CTD | PMID:23358140 |
| oxfendazole | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:20033131 |
| oxfendazole | multiple interactions | EXP | | 6480464 | [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of GSTM1 mRNA | CTD | PMID:18754104 |
| ozone | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism promotes the reaction [NQO1 gene SNP results in increased susceptibility to Ozone] | CTD | PMID:17652311 |
| ozone | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 affects the susceptibility to Ozone | CTD | PMID:22732554 |
| ozone | decreases expression | ISO | RGD:10697 | 6480464 | Ozone results in decreased expression of GSTM1 mRNA | CTD | PMID:12763052 |
| ozone | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the susceptibility to Ozone | CTD | PMID:11371413 |
| ozone | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene SNP results in increased susceptibility to Ozone | CTD | PMID:16870661 |
| ozone | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene SNP affects the reaction [MS4A2 gene SNP affects the susceptibility to Ozone] | CTD | PMID:18269668 |
| ozone | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene SNP affects the reaction [TNF gene SNP affects the susceptibility to Ozone] | CTD | PMID:16456144 |
| paclitaxel | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to [Paclitaxel co-treated with Cisplatin] | CTD | PMID:12851839 |
| paracetamol | decreases expression | ISO | RGD:10697 | 6480464 | Acetaminophen results in decreased expression of GSTM1 mRNA | CTD | PMID:16611625 |
| paracetamol | increases response to substance | ISO | RGD:10697 | 6480464 | GSTM1 results in increased susceptibility to Acetaminophen | CTD | PMID:22687999 |
| paracetamol | multiple interactions | ISO | RGD:10697 | 6480464 | GSTM1 gene mutant form inhibits the reaction [Acetaminophen results in increased phosphorylation of GSK3B protein]; more ... | CTD | PMID:22687999 |
| paraquat | increases expression | ISO | RGD:10697 | 6480464 | Paraquat results in increased expression of GSTM1 mRNA | CTD | PMID:16128001 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:10697 | 6480464 | perfluorooctane sulfonic acid affects the expression of GSTM1 mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:10697 | 6480464 | perfluorooctanoic acid results in decreased expression of GSTM1 mRNA | CTD | PMID:18467677 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:10697 | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of GSTM1 mRNA] | CTD | PMID:18467677 |
| perfluorooctanoic acid | affects expression | ISO | RGD:10697 | 6480464 | perfluorooctanoic acid affects the expression of GSTM1 mRNA | CTD | PMID:18281256 PMID:19429403 |
| phenanthrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism promotes the reaction [CYP1A1 gene polymorphism results in increased metabolism of phenanthrene] | CTD | PMID:17035385 |
| phenanthrene | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of phenanthrene | CTD | PMID:22674470 |
| phenethyl isothiocyanate | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of phenethyl isothiocyanate | CTD | PMID:7826396 |
| phenobarbital | increases expression | ISO | RGD:10697 | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:20403969 |
| phenobarbital | increases expression | ISO | RGD:10697 | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:18723825 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:11328961 more ... |
| phenobarbital | increases expression | ISO | RGD:10697 | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:18723825 PMID:20403969 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 more ... |
| phenobarbital | increases expression | ISO | RGD:10697 | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:20403969 PMID:18723825 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:19695238 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 more ... |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 protein | CTD | PMID:8242872 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 more ... |
| phenobarbital | multiple interactions | EXP | | 6480464 | [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of GSTM1 protein | CTD | PMID:20935162 |
| phenobarbital | decreases expression | ISO | RGD:736060 | 6480464 | Phenobarbital results in decreased expression of GSTM1 protein | CTD | PMID:7986210 |
| phenytoin | multiple interactions | ISO | RGD:10697 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein | CTD | PMID:21224054 |
| phenytoin | increases expression | EXP | | 6480464 | Phenytoin results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 |
| phlorizin | decreases expression | ISO | RGD:10697 | 6480464 | Phlorhizin results in decreased expression of GSTM1 mRNA | CTD | PMID:22538082 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GSTM1 mRNA | CTD | PMID:18544911 |
| piperonyl butoxide | multiple interactions | EXP | | 6480464 | Triterpenes promotes the reaction [Piperonyl Butoxide results in increased expression of GSTM1 mRNA] | CTD | PMID:18544911 |
| pirinixic acid | decreases expression | ISO | RGD:10697 | 6480464 | pirinixic acid results in decreased expression of GSTM1 mRNA | CTD | PMID:18467677 PMID:20813756 |
| pirinixic acid | multiple interactions | ISO | RGD:10697 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GSTM1 mRNA] | CTD | PMID:18467677 |
| prednisone | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Prednisone | CTD | PMID:15713801 |
| pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of GSTM1 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | RGD:10697 | 6480464 | Pregnenolone Carbonitrile promotes the reaction [NR1I2 protein binds to GSTM1 5' UTR] | CTD | PMID:20693526 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:10697 | 6480464 | Pregnenolone Carbonitrile results in increased expression of GSTM1 mRNA | CTD | PMID:18723825 |
| propiconazole | affects expression | EXP | | 6480464 | propiconazole affects the expression of GSTM1 mRNA | CTD | PMID:17383973 |
| propiconazole | increases expression | ISO | RGD:10697 | 6480464 | propiconazole results in increased expression of GSTM1 mRNA | CTD | PMID:21278054 PMID:22334560 |
| propiconazole | increases expression | ISO | RGD:10697 | 6480464 | propiconazole results in increased expression of GSTM1 mRNA | CTD | PMID:21278054 |
| prostaglandin A2 | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of prostaglandin A2 | CTD | PMID:9084911 |
| prostaglandin J2 | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of 9-deoxy-delta-9-prostaglandin D2 | CTD | PMID:9084911 |
| purine-6-thiol | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to 6-Mercaptopurine | CTD | PMID:15713801 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of GSTM1 mRNA | CTD | PMID:20033131 |
| quercetin 3-O-beta-D-glucoside | multiple interactions | EXP | | 6480464 | isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of GSTM1 mRNA] | CTD | PMID:20045035 |
| quinidine | decreases activity | ISO | RGD:736060 | 6480464 | Quinidine results in decreased activity of GSTM1 protein | CTD | PMID:11807801 |
| quinine | decreases activity | ISO | RGD:736060 | 6480464 | Quinine results in decreased activity of GSTM1 protein | CTD | PMID:11807801 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GSTM1 mRNA | CTD | PMID:19228061 |
| riddelliine | decreases expression | EXP | | 6480464 | riddelliine results in decreased expression of GSTM1 mRNA | CTD | PMID:18047727 |
| rifampicin | multiple interactions | ISO | RGD:10697 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of GSTM1 protein | CTD | PMID:21224054 |
| rosiglitazone | affects expression | ISO | RGD:10697 | 6480464 | rosiglitazone affects the expression of GSTM1 mRNA | CTD | PMID:17245590 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:10697 | 6480464 | Buthionine Sulfoximine results in increased expression of GSTM1 mRNA | CTD | PMID:15878706 |
| spermidine | multiple interactions | ISO | RGD:10697 | 6480464 | pimagedine inhibits the reaction [Spermidine results in increased expression of GSTM1 mRNA] | CTD | PMID:12763045 |
| spermidine | increases expression | ISO | RGD:10697 | 6480464 | Spermidine results in increased expression of GSTM1 mRNA | CTD | PMID:12763045 |
| spironolactone | increases expression | ISO | RGD:10697 | 6480464 | Spironolactone results in increased expression of GSTM1 mRNA | CTD | PMID:18723825 |
| styrene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:14979085 more ... |
| styrene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:14751678 more ... |
| styrene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:14751678 more ... |
| styrene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Styrene | CTD | PMID:12717779 more ... |
| styrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the reaction [CYP2E1 protein affects the metabolism of Styrene] | CTD | PMID:12464798 |
| styrene | multiple interactions | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism promotes the reaction [GSTT1 gene polymorphism results in increased susceptibility to Styrene] | CTD | PMID:12016165 |
| styrene | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism results in increased susceptibility to Styrene | CTD | PMID:12016165 |
| styrene oxide | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of styrene oxide | CTD | PMID:11599931 PMID:17689871 |
| styrene oxide | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to styrene oxide | CTD | PMID:14698568 PMID:11424177 |
| styrene oxide | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of styrene oxide | CTD | PMID:17689871 PMID:11599931 |
| styrene oxide | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to styrene oxide | CTD | PMID:11424177 PMID:14698568 |
| styrene oxide | multiple interactions | EXP | | 6480464 | GSTM1 protein affects the metabolism of [styrene oxide co-treated with Glutathione] | CTD | PMID:2604743 |
| styrene oxide | affects metabolic processing | EXP | | 6480464 | GSTM1 protein affects the metabolism of styrene oxide | CTD | PMID:1638515 |
| sulfinpyrazone | multiple interactions | ISO | RGD:736060 | 6480464 | Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine] | CTD | PMID:15044619 |
| sulforaphane | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to sulforafan | CTD | PMID:15623468 |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 mRNA | CTD | PMID:17942926 more ... |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 protein | CTD | PMID:11309284 PMID:19303893 |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 mRNA | CTD | PMID:19071154 more ... |
| sulforaphane | multiple interactions | ISO | RGD:736060 | 6480464 | sulforafan inhibits the reaction [alpha-methylepinine results in increased expression of GSTM1 mRNA] | CTD | PMID:21871945 |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 mRNA | CTD | PMID:20932822 PMID:17942926 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of GSTM1 protein | CTD | PMID:18823965 |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 protein | CTD | PMID:11309284 |
| sulforaphane | multiple interactions | ISO | RGD:10697 | 6480464 | [sulforafan co-treated with dibenzoylmethane] results in increased expression of GSTM1 mRNA | CTD | PMID:17942926 |
| sulforaphane | increases expression | ISO | RGD:10697 | 6480464 | sulforafan results in increased expression of GSTM1 mRNA | CTD | PMID:17942926 PMID:20932822 |
| sulforaphane | multiple interactions | ISO | RGD:10697 | 6480464 | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GSTM1 mRNA] | CTD | PMID:20932822 |
| sulforaphane | affects metabolic processing | ISO | RGD:736060 | 6480464 | GSTM1 protein affects the metabolism of sulforafan | CTD | PMID:7826396 |
| tamibarotene | increases expression | ISO | RGD:736060 | 6480464 | Am 80 results in increased expression of GSTM1 mRNA; more ... | CTD | PMID:15498508 |
| testosterone | multiple interactions | ISO | RGD:736060 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of GSTM1 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | ISO | RGD:736060 | 6480464 | Testosterone results in increased expression of GSTM1 mRNA | CTD | PMID:21592394 |
| testosterone enanthate | affects expression | ISO | RGD:736060 | 6480464 | testosterone enanthate affects the expression of GSTM1 mRNA | CTD | PMID:17440010 |
| tetrachloromethane | increases expression | ISO | RGD:10697 | 6480464 | Carbon Tetrachloride results in increased expression of GSTM1 protein | CTD | PMID:15650968 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased activity of GSTM1 protein; more ... | CTD | PMID:12725062 |
| tetrachloromethane | affects response to substance | EXP | | 6480464 | GSTM1 protein polymorphism affects the susceptibility to Carbon Tetrachloride | CTD | PMID:12611589 |
| tetrachloromethane | decreases activity | EXP | | 6480464 | Carbon Tetrachloride results in decreased activity of GSTM1 protein polymorphism | CTD | PMID:12611589 |
| thimerosal | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 affects the susceptibility to Thimerosal | CTD | PMID:11007341 |
| thioacetamide | multiple interactions | EXP | | 6480464 | Dimethyl Sulfoxide inhibits the reaction [Thioacetamide results in decreased expression of GSTM1 protein] | CTD | PMID:12370186 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of GSTM1 protein | CTD | PMID:12370186 |
| thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GSTM1 mRNA | CTD | PMID:15497818 |
| toluene | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Toluene | CTD | PMID:17292523 |
| toluene 2,4-diisocyanate | increases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein polymorphism results in increased susceptibility to Toluene 2,4-Diisocyanate | CTD | PMID:11927838 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GSTM1 mRNA | CTD | PMID:19228061 |
| trimellitic anhydride | decreases expression | ISO | RGD:10697 | 6480464 | trimellitic anhydride results in decreased expression of GSTM1 mRNA | CTD | PMID:19042947 |
| trimethylarsine oxide | increases expression | EXP | | 6480464 | trimethylarsine oxide results in increased expression of GSTM1 protein; more ... | CTD | PMID:16436460 |
| troglitazone | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to troglitazone | CTD | PMID:12732844 |
| valproic acid | affects expression | ISO | RGD:10697 | 6480464 | Valproic Acid affects the expression of GSTM1 mRNA | CTD | PMID:17292431 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of GSTM1 mRNA | CTD | PMID:17381134 |
| vincristine | affects response to substance | ISO | RGD:736060 | 6480464 | GSTM1 gene polymorphism affects the susceptibility to Vincristine | CTD | PMID:15713801 |
| vincristine | decreases response to substance | ISO | RGD:736060 | 6480464 | GSTM1 protein results in decreased susceptibility to Vincristine | CTD | PMID:15044619 |
| vincristine | multiple interactions | ISO | RGD:736060 | 6480464 | Sulfinpyrazone inhibits the reaction [GSTM1 protein results in decreased susceptibility to Vincristine] | CTD | PMID:15044619 |